Elisabeth Kjellen
Lund, M 22184, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Routinely collected health data on 10-year genitourinary and gastrointestinal morbidity after ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer in the randomised, non-inferiority, phase 3 trial HYPO-RT-PC.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: August 28, 2025
Ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer (HYPO-RT-PC): 10-year outcomes of an open-label, randomised, phase 3, non-inferiority trial.
Journal: The Lancet. Oncology
Published: July 28, 2025
Internal mammary node irradiation in early breast cancer - target coverage and implications on dose to organs at risk.
Journal: Acta oncologica (Stockholm, Sweden)
Published: April 25, 2025
Automated segmentation of target volumes in breast cancer radiotherapy, impact on target size and dose to organs at risk.
Journal: Clinical and translational radiation oncology
Published: March 24, 2025
Ultrahypofractionated Radiation Therapy for Prostate Cancer Including Seminal Vesicles in the Target Volume: A Treatment-planning Study Based on the HYPO-RT-PC Fractionation Schedule.
Journal: Advances in radiation oncology
Published: January 16, 2024
Dose-volume relationships of planned versus estimated delivered radiation doses to pelvic organs at risk and side effects in patients treated with salvage radiotherapy for recurrent prostate cancer.
Journal: Technical innovations & patient support in radiation oncology
Published: October 08, 2023
A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and 68Ga-PSMA-PET for biochemical relapse after radical prostatectomy - The PROPER 1 trial.
Journal: Clinical and translational radiation oncology
Published: March 31, 2022
Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy.
Journal: Radiation oncology (London, England)
Published: February 09, 2022
Results from a prospective, randomised study on (accelerated) preoperative versus (conventional) postoperative radiotherapy in treatment of patients with resectable squamous cell carcinoma of the oral cavity - The ARTSCAN 2 study.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: July 20, 2021
Adaptive sequential plan-on-plan optimization during prostate-specific antigen response guided radiotherapy of recurrent prostate cancer.
Journal: Physics and imaging in radiation oncology
Published: September 11, 2020
Long-Term Risk of Hip Complications After Radiation Therapy for Prostate Cancer: A Dose-Response Study.
Journal: Advances in radiation oncology
Published: June 25, 2020
Last Updated: 09/26/2026